CERES HOMEOPATHIC MEDICINE
LIVE

Serial Number

79112393

Owner

Ceres Heilmittel AG

Attorney

Carl Oppedahl

Filing Date

Mar 23, 2012

Add to watchlist:

No watchlists yet
View on USPTO

CERES HOMEOPATHIC MEDICINE Trademark

Serial Number: 79112393 • Registration: 4810495

CERES HOMEOPATHIC MEDICINE is a trademark filed by Ceres Heilmittel AG on March 23, 2012. The trademark is classified under Class 5 (Pharmaceuticals). The application is currently registered and active.

Owner Contact Info

Ceres Heilmittel AG

Bachtobelstrasse 6
Kesswil CH-8593 , CH

Entity Type: 99

Trademark Details

Filing Date

March 23, 2012

Registration Date

September 15, 2015

Published for Opposition

June 30, 2015

Cancellation Date

March 27, 2026

Goods & Services

Housemark for homeopathic pharmaceutical preparations, excluding antihistamines and excluding diet products for specific medical nutrition, for use in the treatment of a variety of gastrointestinal diseases and conditions, namely, indigestion, heartburn, sour stomach, upset stomach, gas, diarrhea, over indulgence in food and drink, anorexia, bowel irritation and abrasion, hemorrhoidal inflammation and irritation, and anorectal inflammation, but specially excluding homeopathic pharmaceutical preparations used as diet products for specific medical nutrition, for use in the treatment of a variety of dermatologic diseases and conditions, namely, for use in the treatment skin pain, discomfort and itching due to abrasions, burns, fungal infections, eczema, psoriasis, atopic dermatitis, plant toxins and insect bites, and for use in the treatment of hyperpigmentation, scarring acne, dandruff, seborrheic dermatitis, cold sores, fever blisters, fungal infections, warts, and calluses, for use in the treatment of motion sickness, for use in the treatment of sleeplessness and insomnia, for use in the treatment of fatigue and drowsiness, for use in the treatment of bacterial infections, viral infections, swollen lymph glands, fever, pain, allergic rhinitis, chest congestion, coughs, bronchitis, and the common cold, but specifically excluding anti-histamines, for use in the treatment of asthma, for use in the prevention and treatment of cardiovascular disease, for use in the treatment of joint, tendon, ligament and muscle pain and stiffness, for use in the treatment of arthritis and rheumatism, for use in the treatment of a variety of ophthalmic conditions, namely, eye burning, eye irritation, eye strain, and eye discomfort, for use in the treatment of a variety of oral conditions, namely, tooth decay, gingivitis, oral abrasions, wounds, and dry mouth, used for anthelmintic purposes, namely, to expel parasitic worms and parasites, for the treatment of gynecological disorders, namely, pain and discomfort of menses, menopause, and intercourse, for the treatment of urological disorders, namely, urinary tract pain, and frequent urination, for use in the treatment of allergies and hay fever, but specially excluding antihistamines, for the treatment of bloating, pain, indigestion, and discomfort associated with liver disorders; homeopathic pharmaceutical preparations for use in the treatment of a variety of gastrointestinal diseases and conditions, namely, indigestion, heartburn, sour stomach, upset stomach, gas, diarrhea, over indulgence in food and drink, anorexia, bowel irritation and abrasion, hemorrhoidal inflammation and irritation, and anorectal inflammation, but specially excluding homeopathic pharmaceutical preparations used as diet products for specific medical nutrition; homeopathic pharmaceutical preparations for use in the treatment of a variety of dermatologic diseases and conditions, namely, for use in the treatment skin pain, discomfort and itching due to abrasions, burns, fungal infections, eczema, psoriasis, atopic dermatitis, plant toxins and insect bites, and for use in the treatment of hyperpigmentation, scarring acne, dandruff, seborrheic dermatitis, cold sores, fever blisters, fungal infections, warts, and calluses; homeopathic pharmaceutical preparations for use in the treatment of motion sickness; homeopathic pharmaceutical preparations for use in the treatment of sleeplessness and insomnia; homeopathic pharmaceutical preparations for use in the treatment of fatigue and drowsiness; homeopathic pharmaceutical preparations for use in the treatment of bacterial infections, viral infections, swollen lymph glands, fever, pain, allergic rhinitis, chest congestion, coughs, bronchitis, and the common cold, but specifically excluding anti-histamines; homeopathic pharmaceutical preparations for use in the treatment of asthma; homeopathic pharmaceutical preparations for use in the prevention and treatment of cardiovascular disease; homeopathic pharmaceutical preparations for use in the treatment of joint, tendon, ligament and muscle pain and stiffness, and for use in the treatment of arthritis and rheumatism; homeopathic pharmaceuticals for use in the treatment of a variety of ophthalmic conditions, namely, eye burning, eye irritation, eye strain, and eye discomfort; homeopathic pharmaceuticals for use in the treatment of a variety of oral conditions, namely, tooth decay, gingivitis, oral abrasions, wounds, and dry mouth; homeopathic pharmaceutical preparations used for anthelmintic purposes, namely, to expel parasitic worms and parasites; homeopathic preparations for the treatment of gynecological disorders, namely, pain and discomfort of menses, menopause, and intercourse; homeopathic preparations for the treatment of urological disorders, namely, urinary tract pain, and frequent urination; homeopathic pharmaceutical preparations for use in the treatment of allergies and hay fever, but specially excluding antihistamines; homeopathic pharmaceutical preparations for the treatment of bloating, pain, indigestion, and discomfort associated with liver disorders

Filing History

CANCELLED SECTION 71
Mar 27, 2026 C71T
COURTESY REMINDER - SEC. 71 (10-YR) E-MAILED
Sep 15, 2024 REM4
NEW REPRESENTATIVE AT IB RECEIVED
Oct 28, 2023 NREP
NOTICE OF ACCEPTANCE OF SEC. 71 - E-MAILED
May 3, 2022 NA71
REGISTERED-SEC.71 ACCEPTED
May 3, 2022 71AG
INTERNATIONAL REGISTRATION RENEWED
Apr 28, 2022 RNWL
CASE ASSIGNED TO POST REGISTRATION PARALEGAL
Apr 27, 2022 APRE
TEAS SECTION 71 RECEIVED
Sep 15, 2021 ES71
COURTESY REMINDER - SEC. 71 (6-YR) E-MAILED
Sep 15, 2020 REM3
TEAS CHANGE OF CORRESPONDENCE RECEIVED
Dec 20, 2018 TCCA
TEAS CHANGE OF CORRESPONDENCE RECEIVED
Feb 18, 2017 TCCA
FINAL DECISION TRANSACTION PROCESSED BY IB
May 26, 2016 FINO
FINAL DISPOSITION NOTICE SENT TO IB
Mar 17, 2016 FICS
FINAL DISPOSITION PROCESSED
Mar 17, 2016 FIMP
FINAL DISPOSITION NOTICE CREATED, TO BE SENT TO IB
Dec 15, 2015 FICR
REGISTERED-PRINCIPAL REGISTER
Sep 15, 2015 R.PR
OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
Jun 30, 2015 NPUB
PUBLISHED FOR OPPOSITION
Jun 30, 2015 PUBO
NOTIFICATION PROCESSED BY IB
Jun 26, 2015 GPNX
NOTIFICATION OF POSSIBLE OPPOSITION SENT TO IB
Jun 10, 2015 OPNS
NOTICE OF START OF OPPOSITION PERIOD CREATED, TO BE SENT TO IB
Jun 10, 2015 OP2R
NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
Jun 10, 2015 NONP
LAW OFFICE PUBLICATION REVIEW COMPLETED
May 28, 2015 PREV
APPROVED FOR PUB - PRINCIPAL REGISTER
May 26, 2015 CNSA
EXAMINER'S AMENDMENT ENTERED
May 26, 2015 XAEC
NOTIFICATION OF EXAMINERS AMENDMENT E-MAILED
May 26, 2015 GNEN
EXAMINERS AMENDMENT E-MAILED
May 26, 2015 GNEA
EXAMINERS AMENDMENT -WRITTEN
May 26, 2015 CNEA
PREVIOUS ALLOWANCE COUNT WITHDRAWN
May 19, 2015 ZZZX
EXPARTE APPEAL TERMINATED
May 5, 2015 EXPT
WITHDRAWN FROM PUB - OG REVIEW QUERY
Apr 14, 2015 PBCR
LAW OFFICE PUBLICATION REVIEW COMPLETED
Mar 30, 2015 PREV
APPROVED FOR PUB - PRINCIPAL REGISTER
Mar 28, 2015 CNSA
EXAMINER'S AMENDMENT ENTERED
Mar 28, 2015 XAEC
NOTIFICATION OF EXAMINERS AMENDMENT E-MAILED
Mar 28, 2015 GNEN
EXAMINERS AMENDMENT E-MAILED
Mar 28, 2015 GNEA
EXAMINERS AMENDMENT -WRITTEN
Mar 28, 2015 CNEA
TEAS/EMAIL CORRESPONDENCE ENTERED
Mar 11, 2015 TEME
CORRESPONDENCE RECEIVED IN LAW OFFICE
Mar 11, 2015 CRFA
TEAS RESPONSE TO OFFICE ACTION RECEIVED
Mar 9, 2015 TROA
LIMITATION FROM THE IB EXAMINED, NO ACTION IS NEEDED
Sep 15, 2014 LIMN
LIMITATION OF GOODS RECEIVED FROM IB
Sep 11, 2014 LIMG
NOTIFICATION OF NON-FINAL ACTION E-MAILED
Sep 9, 2014 GNRN
NON-FINAL ACTION E-MAILED
Sep 9, 2014 GNRT
NON-FINAL ACTION WRITTEN
Sep 9, 2014 CNRT
TEAS/EMAIL CORRESPONDENCE ENTERED
Aug 25, 2014 TEME
CORRESPONDENCE RECEIVED IN LAW OFFICE
Aug 25, 2014 CRFA
TEAS REQUEST FOR RECONSIDERATION RECEIVED
Aug 18, 2014 ERFR
EX PARTE APPEAL-INSTITUTED
Aug 18, 2014 EXPI
JURISDICTION RESTORED TO EXAMINING ATTORNEY
Aug 18, 2014 JURT
EXPARTE APPEAL RECEIVED AT TTAB
Aug 18, 2014 EXAF
ATTORNEY REVIEW COMPLETED
May 1, 2014 ATRV
LIMITATION OF GOODS/SERVICES FROM IB ENTERED
Apr 30, 2014 LIMS
LIMITATION OF GOODS RECEIVED FROM IB
Feb 28, 2014 LIMG
NOTIFICATION OF FINAL REFUSAL EMAILED
Feb 17, 2014 GNFN
FINAL REFUSAL E-MAILED
Feb 17, 2014 GNFR
FINAL REFUSAL WRITTEN
Feb 17, 2014 CNFR
SUSPENSION CHECKED - TO ATTORNEY FOR ACTION
Feb 3, 2014 RCCK
NOTIFICATION OF POSSIBLE OPPOSITION - PROCESSED BY IB
Nov 13, 2013 OPNX
NOTIFICATION OF POSSIBLE OPPOSITION SENT TO IB
Oct 23, 2013 OPNS
NOTIFICATION OF POSSIBLE OPPOSITION CREATED, TO BE SENT TO IB
Oct 23, 2013 OPNR
REPORT COMPLETED SUSPENSION CHECK CASE STILL SUSPENDED
Jul 29, 2013 RCSC
ASSIGNED TO LIE
Jul 26, 2013 ALIE
LIMITATION OF GOODS/SERVICES FROM IB ENTERED
Jul 18, 2013 LIMS
LIMITATION OF GOODS RECEIVED FROM IB
Jul 13, 2013 LIMG
NOTIFICATION OF LETTER OF SUSPENSION E-MAILED
Jan 24, 2013 GNS3
LETTER OF SUSPENSION E-MAILED
Jan 24, 2013 GNSL
SUSPENSION LETTER WRITTEN
Jan 24, 2013 CNSL
TEAS/EMAIL CORRESPONDENCE ENTERED
Jan 1, 2013 TEME
CORRESPONDENCE RECEIVED IN LAW OFFICE
Dec 31, 2012 CRFA
TEAS RESPONSE TO OFFICE ACTION RECEIVED
Dec 31, 2012 TROA
NEW REPRESENTATIVE AT IB RECEIVED
Nov 23, 2012 NREP
REFUSAL PROCESSED BY IB
Jul 28, 2012 RFNT
NON-FINAL ACTION MAILED - REFUSAL SENT TO IB
Jul 11, 2012 RFCS
REFUSAL PROCESSED BY MPU
Jul 10, 2012 RFRR
NON-FINAL ACTION (IB REFUSAL) PREPARED FOR REVIEW
Jul 8, 2012 RFCR
NON-FINAL ACTION WRITTEN
Jul 7, 2012 CNRT
ASSIGNED TO EXAMINER
Jun 29, 2012 DOCK
APPLICATION FILING RECEIPT MAILED
May 22, 2012 MAFR
NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
May 18, 2012 NWOS
SN ASSIGNED FOR SECT 66A APPL FROM IB
May 17, 2012 REPR